267 related articles for article (PubMed ID: 25960231)
1. Effects of cell-penetrating peptides on transduction efficiency of PEGylated adenovirus.
Nigatu AS; Vupputuri S; Flynn N; Ramsey JD
Biomed Pharmacother; 2015 Apr; 71():153-60. PubMed ID: 25960231
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of cell-penetrating peptide/adenovirus particles for transduction of CAR-negative cells.
Nigatu AS; Vupputuri S; Flynn N; Neely BJ; Ramsey JD
J Pharm Sci; 2013 Jun; 102(6):1981-1993. PubMed ID: 23592439
[TBL] [Abstract][Full Text] [Related]
3. Surface Modification of Adenovirus Vector to Improve Immunogenicity and Tropism.
Gabal Y; Ramsey JD
Methods Mol Biol; 2021; 2183():357-366. PubMed ID: 32959253
[TBL] [Abstract][Full Text] [Related]
4. PEGylated adenovirus vectors containing RGD peptides on the tip of PEG show high transduction efficiency and antibody evasion ability.
Eto Y; Gao JQ; Sekiguchi F; Kurachi S; Katayama K; Maeda M; Kawasaki K; Mizuguchi H; Hayakawa T; Tsutsumi Y; Mayumi T; Nakagawa S
J Gene Med; 2005 May; 7(5):604-12. PubMed ID: 15543536
[TBL] [Abstract][Full Text] [Related]
5. Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs.
Nguyen J; Xie X; Neu M; Dumitrascu R; Reul R; Sitterberg J; Bakowsky U; Schermuly R; Fink L; Schmehl T; Gessler T; Seeger W; Kissel T
J Gene Med; 2008 Nov; 10(11):1236-46. PubMed ID: 18780309
[TBL] [Abstract][Full Text] [Related]
6. Transduction of adenovirus vectors modified with cell-penetrating peptides.
Eto Y; Yoshioka Y; Asavatanabodee R; Kida S; Maeda M; Mukai Y; Mizuguchi H; Kawasaki K; Okada N; Nakagawa S
Peptides; 2009 Aug; 30(8):1548-52. PubMed ID: 19467282
[TBL] [Abstract][Full Text] [Related]
7. Active targeting and safety profile of PEG-modified adenovirus conjugated with herceptin.
Kim PH; Sohn JH; Choi JW; Jung Y; Kim SW; Haam S; Yun CO
Biomaterials; 2011 Mar; 32(9):2314-26. PubMed ID: 21227505
[TBL] [Abstract][Full Text] [Related]
8. Development of PEGylated adenovirus vector with targeting ligand.
Eto Y; Yoshioka Y; Mukai Y; Okada N; Nakagawa S
Int J Pharm; 2008 Apr; 354(1-2):3-8. PubMed ID: 17904316
[TBL] [Abstract][Full Text] [Related]
9. Effective tumor targeted gene transfer using PEGylated adenovirus vector via systemic administration.
Gao JQ; Eto Y; Yoshioka Y; Sekiguchi F; Kurachi S; Morishige T; Yao X; Watanabe H; Asavatanabodee R; Sakurai F; Mizuguchi H; Okada Y; Mukai Y; Tsutsumi Y; Mayumi T; Okada N; Nakagawa S
J Control Release; 2007 Sep; 122(1):102-10. PubMed ID: 17628160
[TBL] [Abstract][Full Text] [Related]
10. Modification of an adenoviral vector with biologically selected peptides: a novel strategy for gene delivery to cells of choice.
Romanczuk H; Galer CE; Zabner J; Barsomian G; Wadsworth SC; O'Riordan CR
Hum Gene Ther; 1999 Nov; 10(16):2615-26. PubMed ID: 10566889
[TBL] [Abstract][Full Text] [Related]
11. A novel strategy to modify adenovirus tropism and enhance transgene delivery to activated vascular endothelial cells in vitro and in vivo.
Ogawara K; Rots MG; Kok RJ; Moorlag HE; Van Loenen AM; Meijer DK; Haisma HJ; Molema G
Hum Gene Ther; 2004 May; 15(5):433-43. PubMed ID: 15144574
[TBL] [Abstract][Full Text] [Related]
12. Hepatoma targeting peptide conjugated bio-reducible polymer complexed with oncolytic adenovirus for cancer gene therapy.
Choi JW; Kim HA; Nam K; Na Y; Yun CO; Kim S
J Control Release; 2015 Dec; 220(Pt B):691-703. PubMed ID: 26437261
[TBL] [Abstract][Full Text] [Related]
13. Identification of Adenovirus-Derived Cell-Penetrating Peptide.
Hirai T; Yamagishi Y; Koizumi N; Nonaka M; Mochida R; Shida K; Nomura T; Fujii M; Sakurai F; Mizuguchi H; Watanabe Y; Utoguchi N
Biol Pharm Bull; 2017; 40(2):195-204. PubMed ID: 28154260
[TBL] [Abstract][Full Text] [Related]
14. Hexon-specific PEGylated adenovirus vectors utilizing avidin-biotin interaction.
Suzuki-Kouyama E; Katayama K; Sakurai F; Yamaguchi T; Kurachi S; Kawabata K; Nakagawa S; Mizuguchi H
Biomaterials; 2011 Feb; 32(6):1724-30. PubMed ID: 21106235
[TBL] [Abstract][Full Text] [Related]
15. PEGylated liposomes with NGR ligand and heat-activable cell-penetrating peptide-doxorubicin conjugate for tumor-specific therapy.
Yang Y; Yang Y; Xie X; Cai X; Zhang H; Gong W; Wang Z; Mei X
Biomaterials; 2014 May; 35(14):4368-81. PubMed ID: 24565519
[TBL] [Abstract][Full Text] [Related]
16. Branched oligomerization of cell-permeable peptides markedly enhances the transduction efficiency of adenovirus into mesenchymal stem cells.
Park SH; Doh J; Park SI; Lim JY; Kim SM; Youn JI; Jin HT; Seo SH; Song MY; Sung SY; Kim M; Hwang SJ; Choi JM; Lee SK; Lee HY; Lim CL; Chung YJ; Yang D; Kim HN; Lee ZH; Choi KY; Jeun SS; Sung YC
Gene Ther; 2010 Aug; 17(8):1052-61. PubMed ID: 20485381
[TBL] [Abstract][Full Text] [Related]
17. On the importance of electrostatic interactions between cell penetrating peptides and membranes: a pathway toward tumor cell selectivity?
Jobin ML; Alves ID
Biochimie; 2014 Dec; 107 Pt A():154-9. PubMed ID: 25107405
[TBL] [Abstract][Full Text] [Related]
18. Fully detargeted polyethylene glycol-coated adenovirus vectors are potent genetic vaccines and escape from pre-existing anti-adenovirus antibodies.
Wortmann A; Vöhringer S; Engler T; Corjon S; Schirmbeck R; Reimann J; Kochanek S; Kreppel F
Mol Ther; 2008 Jan; 16(1):154-62. PubMed ID: 17848961
[TBL] [Abstract][Full Text] [Related]
19. Adenoviral vectors coated with PAMAM dendrimer conjugates allow CAR independent virus uptake and targeting to the EGF receptor.
Vetter A; Virdi KS; Espenlaub S; Rödl W; Wagner E; Holm PS; Scheu C; Kreppel F; Spitzweg C; Ogris M
Mol Pharm; 2013 Feb; 10(2):606-18. PubMed ID: 23281933
[TBL] [Abstract][Full Text] [Related]
20. Polyethylene glycol-grafted polyethylenimine used to enhance adenovirus gene delivery.
Singarapu K; Pal I; Ramsey JD
J Biomed Mater Res A; 2013 Jul; 101(7):1857-64. PubMed ID: 23712991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
